YD Bio Ltd (YDES) Ownership
YDES ownership summary
as of October 18, 2026- Institutions
- 0.4% of shares outstanding
- Insiders
- 80.22% of shares outstanding
- Shares outstanding
- 70.8M
- Float
- 16.2M shares available to trade
- Short interest
- 1.08% 177K shares short
- Days to cover
- 0.26 short interest up 312.8% vs prior month
- Institutions 0.40%
- Insiders 80.22%
- Other investors 19.38%
YDES top institutional holders
15 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Garrett Wealth Advisory Group, LLC | 0.12% | 85K | $501,010 | +84,630 (0.0%) | June 30, 2026 |
| 2 | Geode Capital Management, LLC | 0.09% | 63K | $371,267 | +2,478 (+4.1%) | June 30, 2026 |
| 3 | Cypress Capital Management, LLC | 0.05% | 34K | $199,445 | +3,000 (+9.8%) | June 30, 2026 |
| 4 | HPM Partners LLC | 0.05% | 32K | $191,844 | — | June 30, 2026 |
| 5 | Citadel Advisors Llc | 0.04% | 30K | $178,228 | +10,656 (+54.8%) | June 30, 2026 |
| 6 | Jane Street Group LLC | 0.03% | 21K | $126,824 | +21,423 (0.0%) | June 30, 2026 |
| 7 | UBS Group AG | 0.02% | 12K | $73,313 | +756 (+6.5%) | June 30, 2026 |
| 8 | Wolverine Asset Management LLC | 0.01% | 4,886 | $28,925 | — | June 30, 2026 |
| 9 | SkyView Investment Advisors, LLC | <0.01% | 1,777 | $10,520 | +1,777 (0.0%) | June 30, 2026 |
| 10 | Morgan Stanley - Brokerage Accounts | <0.01% | 160 | $947 | −63 (−28.3%) | June 30, 2026 |
| 11 | Royal Bank of Canada | <0.01% | 117 | $693 | +117 (0.0%) | June 30, 2026 |
| 12 | Wells Fargo & Co | <0.01% | 75 | $444 | +75 (0.0%) | June 30, 2026 |
| 13 | FMR Inc | 0.00% | 1 | $6 | — | June 30, 2026 |
| 14 | Citigroup Inc | 0.00% | — | — | −1,709 (−100.0%) | March 31, 2026 |
| 15 | Bank of America Corp | 0.00% | — | — | −5 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 15, 9 holders added 125K shares and 3 cut 1,777.
YDES top mutual fund and ETF holders
2 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 0.06% | 45K | $266,057 | — | August 31, 2026 |
| 2 | Arrow Long/Short Alt Fd F | 0.03% | 21K | $124,320 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
YDES shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns YDES
Institutional investors own 0.4% of YD Bio's shares and insiders 80.22%. The largest holder is Garrett Wealth Advisory Group, LLC with 0.12% of the shares (85K), as of June 30, 2026. Among the top 15 institutions, 9 added shares and 3 reduced their stake in the latest filings. Short interest is 1.08% of the float, or 0.26 days of average trading volume. The share count rose 1,540.3% since 2023.
Related: YDES key metrics. See the YDES stock overview for the latest quote and news.
YDES ownership FAQ
Who owns the most YD Bio stock?
The largest shareholders of YD Bio are Garrett Wealth Advisory Group, LLC (0.12%), Geode Capital Management, LLC (0.09%), Cypress Capital Management, LLC (0.05%), HPM Partners LLC (0.05%), Citadel Advisors Llc (0.04%).
What percentage of YD Bio is owned by institutions?
Institutions hold 0.4% of YD Bio's shares outstanding; insiders hold 80.22%.
Which funds own YD Bio?
The largest fund holders of YD Bio are Fidelity Nasdaq Composite Index (0.06%), Arrow Long/Short Alt Fd F (0.03%).
What is YD Bio's short interest?
177K shares of YD Bio were sold short, 1.08% of the float; at the average daily volume it would take 0.26 days to cover.
How many shares of YD Bio are outstanding?
YD Bio has 70.8M shares outstanding, of which 16.2M are in the public float.